mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.04 |
0.5 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.5 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.5 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.5 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.5 |